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Summary
 
Migration of mature B lymphocytes within secondary lymphoid organs and recirculation be-
tween these sites are thought to allow B cells to obtain T cell help, to undergo somatic hyper-
mutation, to differentiate into effector cells, and to home to sites of antibody production. The
mechanisms that direct migration of B lymphocytes are unknown, but there is evidence that G
protein–coupled receptors, and possibly chemokine receptors, may be involved. Stromal cell–
derived factor (SDF)-1
 
a
 
 is a CXC chemokine previously characterized as an efficacious
chemoattractant for T lymphocytes and monocytes in peripheral blood. Here we show with
purified tonsillar B cells that SDF-1
 
a
 
 also attracts naive and memory, but not germinal center
(GC) B lymphocytes. Furthermore, GC B cells could be converted to respond to SDF-1
 
a
 
 by
in vitro differentiation into memory B lymphocytes. Conversely, the migratory response in na-
ive and memory B cells was significantly reduced after B cell receptor engagement and CD40
signaling. The receptor for SDF-1, CXC chemokine receptor 4 (CXCR4), was found to be
expressed on responsive as well as unresponsive B cell subsets, but was more rapidly downreg-
ulated on responsive cells by ligand. Finally, messenger RNA for SDF-1 was detected by in situ
hybridization in a layer of cells surrounding the GC. These findings show that responsiveness
to the chemoattractant SDF-1
 
a
 
 is regulated during B lymphocyte activation, and correlates
with positioning of B lymphocytes within a secondary lymphoid organ.
 
M
 
ature B lymphocytes are known to localize to dis-
tinct microenvironments within secondary lymphoid
organs such as the spleen, peripheral and mesenteric lymph
nodes, and Peyer’s patches in the gut. In the spleen, these
microenvironments are located in the white pulp and sup-
port antigen- and costimulus-dependent proliferation in
the T cell zone (periarteriolar lymphocyte sheath, PALS)
and affinity maturation in the germinal center (GC)
 
1
 
 within
the B cell area or follicle. Corresponding compartments can
be found in the other secondary lymphoid organs. Early
studies in the rat have shown that recirculating B cells col-
lected from the thoracic duct home to the follicular mantle
zone, i.e., the B cell area surrounding GCs, but not to the
GC itself (1, 2). A large body of work on the generation of
T cell–dependent antibody responses suggests that B lym-
phocytes after encounter of antigen and B cell receptor
(BCR) engagement are initially activated by cognate inter-
action with T lymphocytes in the T cell zone (3–5). B cells
then move to the follicle where they form germinal centers
in which they undergo somatic hypermutation and affinity
maturation. After the GC reaction wanes, some memory B
cells are thought to remain in close proximity to follicular
dendritic cells within the B cell area, whereas others recir-
culate or migrate together with antibody-secreting cells
into the bone marrow (6).
The regulated movement of B lymphocytes into sup-
portive niches is thought to prevent autoreactivity. Good-
now and coworkers have demonstrated that in the presence
of a polyclonal B cell repertoire, a process termed follicular
exclusion hinders autoreactive B cells from entering the B
cell zone, which is a prerequisite for their survival in the
absence of T cell help (7–9). Follicular exclusion has been
proposed to be due to subtle differences between autoreac-
tive and nonautoreactive B cells in responsiveness to posi-
tioning cues and is thought to be a checkpoint for censor-
ing autoreactive B cells from the preimmune repertoire (9).
This concept has recently been challenged by studies show-
ing that BCR engagement and not the presence or absence
 
1
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BCR, B cell receptor; BLR1, Burkitt’s lym-
phoma receptor 1; DIG, digxigenin; F-actin, filamentous actin; GC, ger-
minal center; IP10, interferon-inducible protein 10; L, ligand; Mig,
monokine-induced by IFN-
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; MIP, macrophage inflammatory protein;
mRNA, messenger RNA; SDF, stromal cell–derived factor; SSC, stan-
dard saline citrate; t, transfected.
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of a polyclonal B cell repertoire is the key factor that leads
to arrest of B cells in the outer periarteriolar lymphoid
sheath (10, 11).
The molecular mechanisms that govern localization of B
cells within secondary lymphoid organs and between these
sites are unknown, but some studies suggest the involve-
ment of seven transmembrane receptors and signaling
through pertussis-toxin–sensitive G proteins. Goodnow’s
group has shown in transfer experiments that pretreatment
with pertussis-toxin inhibits the migration of B and T cells
into the splenic white pulp indicating that a G protein–
coupled receptor, and perhaps one that binds a chemotactic
factor, may be necessary for attraction of lymphocytes into
the white pulp (12). A recent study provides evidence for a
role of the putative chemokine receptor Burkitt’s lym-
phoma receptor 1 (BLR1) in B cell migration. The pheno-
type of BLR1-deficient mice suggests the importance of
this receptor in the localization of B lymphocytes within
follicles in the spleen (13).
The role of chemotactic factors in directing granulo-
cytes, macrophages, and T lymphocytes from the blood-
stream into sites of inflammation has been extensively in-
vestigated (14, 15), but very little is known about B
lymphocyte chemoattractants and their receptors. To char-
acterize chemoattractant-induced B cell migration, we car-
ried out chemotaxis assays with stromal cell–derived factor
(SDF)-1
 
a
 
, which we have shown to be an efficacious
chemoattractant for monocytes and lymphocytes, including
the CD4
 
1
 
 and CD8
 
1
 
 T lymphocyte subsets, and the
CD45RA
 
1
 
 naive and CD45RO
 
1
 
 memory T lymphocyte
subsets in peripheral blood (16). SDF-1 is unique among
chemotactic cytokines. Formally, SDF-1 belongs to the
CXC subfamily of a family of small, 60–80 amino acid
chemotactic cytokines termed chemokines. All other hu-
man CXC chemokine genes cluster on chromosome 4; the
 
sdf-1
 
 gene is located on chromosome 10 (17). SDF-1 is
with 99% identity between mouse and human the most
highly conserved cytokine described to date (16, 17). Mice
genetically deficient in SDF-1 lack B lymphocytes, lack
myelopoiesis in the bone marrow, and show defects in
heart development (18). Such a severe phenotype has not
been described for any other chemokine and demonstrates
wide importance for SDF-1 in both hematopoietic and
nonhematopoietic organs. The defect in B cell develop-
ment is in agreement with the finding that SDF-1 functions
as a pre–B cell growth-stimulating factor (19).
It has recently been shown that SDF-1
 
a
 
 binds the CXC
chemokine receptor 4 (CXCR4; references 20, 21). CXCR4,
also known as LESTR/fusin, facilitates entry of T cell line–
tropic strains of HIV-1 into CD4-expressing cells (22). By
binding to CXCR4, SDF-1
 
a
 
 blocks infection by these
strains of HIV-1 (20, 21). Expression of CXCR4 messen-
ger RNA (mRNA) has been detected in a wide variety of
tissues (23–25) and we have found expression of CXCR4
on T and B lymphocytes on the protein level (26).
B lymphocytes differ from T lymphocytes in that they
can undergo a second round of antigen receptor editing.
During development, both T and B lymphocytes go
through VDJ recombination in a primary lymphoid organ.
However, after encounter of antigen, B lymphocytes un-
dergo somatic hypermutation, and also further recombina-
tion, in a specialized microenvironment in secondary lym-
phoid organs, the GC. The surface phenotype of tonsillar B
cells are characteristic for the localization in the different
compartments of the human tonsil and have been well
characterized. Here, we investigate the responsiveness to
SDF-1
 
a
 
 of tonsillar B lymphocytes with distinct surface
phenotypes corresponding to different microenvironments
within this secondary lymphoid organ.
 
Materials and Methods
 
Cytokines, Chemokines, and Antibodies.
 
IL-2 was a kind gift of
Dr. J. Ritz (Dana Farber Cancer Institute, Boston, MA) and IL-10
was purchased from Genzyme (Cambridge, MA). Synthetic, hu-
man SDF-1
 
a
 
(1–67) (20) was a gift of Dr. I. Clark-Lewis (Univer-
sity of British Columbia, Vancouver, Canada). IL-8, macrophage
inflammatory protein (MIP)-1
 
a
 
, MIP-1
 
b
 
, monocyte chemoat-
tractant (MCP)-1, and regulated on activation normal T cell ex-
pressed and secreted (RANTES) were obtained from Genzyme,
monokine induced by IFN-
 
g
 
 (Mig) from PharMingen (San Di-
ego, CA), interferon-inducible protein 10 (IP10) from R&D Sys.
Inc. (Minneapolis, MN), and lymphotactin from Peprotec
(Rocky Hill, NJ). The following mAbs and polyclonal antibodies
were used for staining of surface antigens: anti-kappa-FITC was
obtained from Dako (Carpinteria, CA); anti–intercellular adhe-
sion molecule (ICAM)-1–PE, and anti-CD20-FITC and -PerCP,
anti-CD44-FITC, anti-CD56-FITC, anti-CD62 ligand (L)-FITC,
anti-CD3-PerCP, anti-CD14-PE, and anti-CD38-PE from Bec-
ton Dickinson (San Jose, CA); anti-CD38-TC from CALTAG
Labs. (Burlingame, CA); anti–lymphocyte function-associated an-
tigen (LFA)-3–FITC (CD58) from Amac (Westbrook, ME); anti-
CXCR4-PE (12G5) from PharMingen; anti-B7.1 (CD80) was
obtained from Repligen (Cambridge, MA) and conjugated with
FITC in our laboratory. The CCR3-specific mAb 7B11 (27) was
a gift from Dr. C.R. Mackay (LeukoSite Inc., Cambridge, MA),
and the mAb 12G5 against CXCR4 (28) was supplied by Dr. J.
Hoxie (University of Pennsylvania, Philadelphia, PA). Unconju-
gated mAbs directed against CD38, CD44, kappa, and lambda
light chain were obtained from Immunotech (Westbrook, ME),
and mAbs against CD14 and CD3 from Coulter Corp. (Miami,
FL). An mAb against CD40 was purchased from the American
Type Culture Collection (Rockville, MD). The annexin V apop-
tosis detection assay was carried out according to the manufac-
turer’s recommendations (R&D Sys. Inc.).
 
B Lymphocyte Purification.
 
Fresh tonsils were obtained from
the Massachusetts Eye and Ear Infirmary (Boston, MA). Tonsils
were mechanically homogenized. Tonsillar B lymphocytes were
obtained from the single cell suspension by rosetting with sheep
red blood cells (BioWhittaker, Walkersville, MD). The purity of
tonsillar B cells obtained with this method was routinely 
 
.
 
96% as
estimated by FACScan
 
Ò
 
 analysis (Becton Dickinson, San Jose,
CA) using mAb to CD20, CD19, CD3, CD4, CD8, and CD14.
Subsets of tonsillar B cells were purified by negative selection us-
ing a magnetic cell separation protocol (MACS; Miltenyi Biotec,
Sunnyvale, CA). In brief, tonsillar B cells were incubated with
mAbs specific for CD3, CD14, and either CD38 (for naive and
memory B cell preparation), or CD44 (for GC B cell preparation),
and subsequently with magnetic beads coated with anti–mouse
IgG antibodies. Unstained cells were separated on a MACS col- 
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umn applying a magnetic field. The purity of CD38
 
1
 
CD44
 
2
 
 GC B
cells and CD38
 
2
 
CD44
 
1
 
 naive and memory B cells was routinely
 
.
 
97% as estimated by FACScan
 
Ò
 
 analysis. Three-color flow cy-
tometry was carried out as previously described (26). For chemokine
receptor downmodulation, tonsillar B cells were incubated for 30
min at 37
 
8
 
C or 4
 
8
 
C in RPMI-1640 containing 0.25% human se-
rum albumin in the presence or absence of 2 
 
m
 
g/ml SDF-1
 
a
 
,
washed twice, and stained using the appropriate mAbs.
 
Chemotaxis Assays.
 
Chemotaxis assays were carried out as de-
scribed (16) with the exception that tonsillar B lymphocytes were
migrated for a period of 4 h and B cell subsets for a period of 3 h.
In brief, 5 
 
3
 
 10
 
5
 
 B cells in 100 
 
m
 
l RPMI-1640 containing 0.25%
human serum albumin were transmigrated through 5-
 
m
 
m pore
size bare filter Transwell inserts (Costar, Cambridge, MA). Mi-
grated cells were counted by FACS
 
Ò
 
 analysis scatter gating on
lymphocytes. For antibody inhibition, cells were incubated for 15
min with differing concentrations of mAb to CXCR4 (12G5) or
CCR3 (7B11) before addition to the top chamber of the chemo-
taxis assay. Chemotaxis was then carried out in the presence of
mAb to an optimal concentration of 1.5 
 
m
 
g/ml SDF-1
 
a
 
. For per-
tussis toxin treatment, CD38
 
2
 
 naive and memory B lymphocytes
were incubated for 2 h at 37
 
8
 
C with 200 ng/ml pertussis toxin
(GIBCO BRL, Gaithersburg, MD), washed twice, and subse-
quently added to the top chamber of the chemotaxis assay. Re-
sults are shown as percentage of total input or specific migration
after subtraction of background migration to control medium.
 
Actin polymerization.
 
Actin polymerization was tested as de-
scribed (16, 29). In brief, human B cell subsets (1.25 
 
3
 
 10
 
6
 
/ml)
were incubated in L15 medium at 37
 
8
 
C with or without SDF-1
 
a
 
at 1.5 
 
m
 
g/ml. At the indicated time points, cells (400 
 
m
 
l) were
added to 100 
 
m
 
l of a solution containing 4 
 
3
 
 10
 
2
 
7
 
 M FITC-
labeled phalloidin, 0.5 mg/ml 
 
l
 
-
 
a
 
-lysophosphatidylcholine (both
Sigma Chemical Co., Milwaukee, WI), and 18% formaldehyde in
PBS. The fixed cells were subjected to fluorescence flow cytome-
try and the mean relative fluorescence of each sample determined.
All data points are plotted relative to the mean relative fluores-
cence of the sample before addition of chemoattractant.
 
In Vitro Generation of Memory B Cells.
 
Purified GC B cells were
differentiated into memory type B cells in vitro as described (30).
In brief, irradiated CD40L-transfected NIH3T3 cells (transfected
[t]-CD40L; reference 31) were plated onto 24-well plates at 10
 
5
 
cells per well and adhered overnight. GC B cells were plated on
t-CD40L in Iscove’s modified Dulbecco’s medium supplemented
with 2% human AB serum, 1% human serum albumin, 50 
 
m
 
g/ml
transferrin, 5 
 
m
 
g/ml insulin, and 15 
 
m
 
g/ml gentamicin (B cell
medium) containing IL-2 (10 U/ml) and IL-10 (10 ng/ml). B
cells were cultured at 37
 
8
 
C in 5% CO
 
2
 
 for 3 d followed by 4 d of
reculture on freshly prepared t-CD40L cells in the presence of
IL-2 and IL-10.
 
Short-term BCR Cross-linking.
 
BCR and CD40 on CD38
 
2
 
naive and memory B cells were cross-linked for 2 h on Fc
 
g
 
RII
(CD32) transfectants. Irradiated CD32-transfected NIH3T3 cells
(t-CD32, a gift of Dr. J. Fingeroff, Dana-Farber Cancer Institute,
Boston MA) were plated onto 24-well plates at 1–1.5 
 
3
 
 10
 
5
 
cells/well and adhered overnight. mAbs to human kappa and
lambda light chain (2 
 
m
 
g/ml; both IgG1) with or without a mAb
to CD40 (10 
 
m
 
g/ml) were preincubated on t-CD32 cells in B cell
medium for 15 min before purified CD38
 
2
 
 naive and memory B
cells were added at 10
 
6
 
 cells/ml/well. An irrelevant mAb (IgG1)
was used as control. BCR/CD40 cross-linking was carried out
for 2 h at 37
 
8
 
C. Treated cells were assayed in the chemotaxis as-
say to an optimal concentration of SDF-1
 
a
 
 of 1.5 
 
m
 
g/ml.
 
In Situ Hybridization.
 
Digoxigenin (DIG)-labeled SDF-1
RNA probes were prepared by cloning a reverse transcriptase
PCR product from total human tonsillar RNA (5
 
9
 
-primer: GC-
CATGAACGCCAAGGTCGT and 3
 
9
 
-primer: CGGGTCAAT-
GCACACTTGTC) into pCR-II (Invitrogen, San Diego, CA).
This PCR product contains sequence that is common to both
SDF-1
 
a
 
 and SDF-1
 
b
 
. Two clones carrying the insert in either
orientation were identified and DIG-labeled sense and antisense
RNA probes were generated after linearization with HindIII us-
ing T7 RNA polymerase according to the manufacturer’s recom-
mendations (Boehringer Mannheim GmbH, Mannheim, Ger-
many). Control RNA/DNA hybridization on nitrocellulose
filters using the DIG nucleic acid detection kit (Boehringer Mann-
heim GmbH) showed equal incorporation of DIG label in the
two probes.
In situ hybridization was carried out on 10-
 
m
 
m frozen sections
of human tonsil as described (32). In brief, freshly prepared sec-
tions were delipidized in chloroform for 5 min and fixed in PBS
containing 4% paraformaldehyde. After fixation, sections were
washed briefly once in PBS and twice in 2
 
3
 
 standard saline citrate
(SSC), and prehybridized with hybridization buffer containing 4
 
3
 
SSC, 10% dextran sulfate, 1
 
3
 
 Denhardt’s solution, 2 mM EDTA,
50% deionized formamide, and 500 
 
m
 
g/ml herring sperm DNA
for 1 h at 37
 
8
 
C. Sections were subsequently covered with hybrid-
ization buffer containing 200 ng/ml DIG-labeled sense or anti-
sense RNA probe at 37
 
8
 
C for 16 h. After washing the slides at
37
 
8
 
C with 2
 
3
 
 SSC for 5 min and 60% formamide, 0.2
 
3
 
 SSC for
15 min and subsequently at room temperature with 2
 
3
 
 SSC for
10 min sections were blocked with a saturated solution of block-
ing reagent (Boehringer Mannheim GmbH) in 100 mM Tris-
HCl (pH 7.5) and 150 mM NaCl for 30 min. Sections were then
incubated with a 1:200 dilution of alkaline phosphatase–conju-
gated anti-DIG antibody in the saturated blocking solution for 2 h.
After washing with 100 mM Tris-HCl (pH 7.5) and 150 mM
NaCl for 20 min, sections were developed over 16 h using ni-
troblue tetrazolium salt/5-bromo-4-chloro-3-indolyl phosphate
(NBT/BCIP) according to the manufacturer’s recommendations
(Boehringer Mannheim GmbH).
 
Results
 
Chemotaxis in B Lymphocytes.
 
To characterize chemo-
tactic responses in B lymphocytes we used purified human
tonsillar B cells in a chemotaxis assay with bare polycarbon-
ate filters with 5-
 
m
 
m pores as part of a Transwell insert (16,
33). In contrast to the Boyden chamber microchemotaxis
assay, this assay allows the determination of the absolute
number of responsive cells and the collection and charac-
terization of transmigrated cells. Tonsillar B lymphocytes
were chosen because they comprise subpopulations in mul-
tiple states of activation and differentiation that have been
well characterized according to their surface antigen ex-
pression and localization in tonsil (34–37). Using the bare
filter chemotaxis assay, we detected specific migration of a
small fraction of tonsillar B cells towards SDF-1
 
a
 
, which
peaked at a concentration of 1.5 
 
m
 
g/ml of the chemokine
and showed the typical biphasic curve that is characteristic
for chemoattractant induced migration (Fig. 1 
 
A
 
, 
 
top
 
). The
same concentration was found to be optimal for T lympho-
cyte chemotaxis (16). Depending on the donor, the per-
centage of responsive cells varied in nine independent ex-
periments between 6 and 20% of total input (data not 
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shown). Chemotaxis of tonsillar B cells was partially inhib-
ited by preincubation of input cells with the mAb 12G5
(28) directed against the receptor for SDF-1, CXCR4 (Fig.
1 
 
A
 
, 
 
bottom
 
). Preincubation with a control mAb directed
against CCR3; reference 27) was without any effect. Since
SDF-1
 
a
 
–stimulated Ca
 
2
 
1
 
 flux in CXCR4 transfectants is
only partially inhibited by mAb 12G5 (26) only partial in-
hibition of B lymphocyte chemotaxis to SDF-1
 
a
 
 would be
expected. It also is possible that SDF-1
 
a
 
 may use addi-
tional, as yet unidentified, receptors on B lymphocytes.
The CXC chemokines IL-8, Mig, and IP10, the CC
chemokines MIP-1
 
a, MIP-1b, monocyte chemoattractant
protein 1, and regulated on activation normal T cell ex-
pressed and secreted (RANTES), the C chemokine lym-
photactin, and the chemoattractant C5a were also tested for
their ability to induce chemotaxis in tonsillar B lympho-
cytes over a 1,000-fold concentration range in the same as-
say. None of the tested chemokines induced significant mi-
gration in at least two independent experiments. Although
a low amount of activity was seen with Mig and IP10 in
some experiments, this was not a consistent finding (data
not shown).
Characterization of SDF-1a Responsive B Lymphocyte Sub-
sets. We collected and phenotyped transmigrated tonsillar
B cells. Three main subpopulations have been described (3,
34–39). GC B cells express CD38, high levels of CD20, and
little to no CD44 and surface immunoglobulin. B cells outside
the GC are negative for CD38, and express CD44 and inter-
mediate levels of CD20. B cells outside the GC can be divided
into CD382CD441IgD1 naive and CD382CD441IgD2
memory B lymphocytes. The input population of purified
tonsillar B cells contained about two-fold more CD381
GC B cells than CD382 cells (Fig. 1 B, upper left). By con-
trast, almost all transmigrated cells were negative for CD38
(Fig. 1 B, upper right). Among transmigrated B lympho-
cytes, half were CD382IgD1 naive and the other half were
CD382IgD2 memory B cells (Fig. 1 B, lower right). Both
subpopulations were present in the input population in a
similar 1:1 ratio (Fig. 1 B, lower left). CD381 GC B cells
were consistently unresponsive in 11 independent experi-
ments.
GC B cells are large, blast-like lymphocytes that are
thought to undergo somatic hypermutation within the spe-
cialized microenvironment of the GC. It is unlikely,
though, that the unresponsiveness to SDF-1a is due to the
increased size of GC B lymphocytes, since phytohemagglu-
tinin-stimulated T lymphocyte blasts that are even larger in
size than GC B cells as estimated by forward light scatter
readily respond to SDF-1a in the same assay (26). It has
been shown that isolated GC B cells rapidly undergo apop-
tosis (40). To monitor apoptosis among input tonsillar B
lymphocytes, we tested input cells at different time points
over the 4-h duration of the chemotaxis assay for binding
of annexin V. Loss of membrane phospholipid asymmetry,
which leads to surface binding of annexin V, is thought to
be an early marker of programmed cell death (41). We
found that after 2 h, z20% and after 4 h, z30% of input
cells bound annexin V, indicating that the majority of input
GC cells remained intact during the course of the assay.
To confirm the unresponsiveness of GC B lymphocytes
to SDF-1a we carried out chemotaxis assays with isolated
B cell subsets. Purified CD381 GC B cells showed little, if
any, specific migration above background (Fig. 2 A),
whereas 50–80% of isolated CD382 naive and memory B
lymphocytes migrated to an optimal concentration of SDF-1a
of 1.5 mg/ml in the same assay (Fig. 2 A). Specific migra-
Figure 1. SDF-1a induces chemotaxis in CD382 naive and memory B
lymphocytes, but not GC B cells from human tonsil. (A) Human tonsillar
B lymphocytes were assayed in the bare filter chemotaxis assay with poly-
carbonate filters as part of a Transwell insert for migration to different
concentrations of SDF-1a. Control shows migration to buffer alone. For
antibody inhibition, human tonsillar B lymphocytes were preincubated
for 15 min at the given concentrations of mAbs against the chemokine re-
ceptors CXCR4 (12G5 mAb) and CCR3 (7B11 mAb), respectively, be-
fore addition to the chemotaxis assay. Results are indicated as percent of
total input, and error bars show the range of duplicates. The results are
representative of four independent experiments. (B) Human tonsillar B
lymphocytes were subjected to chemotaxis, and input and transmigrated
populations were phenotyped by flow cytometry. Percentages of cells in
the respective quadrants are indicated.757 Bleul et al.
tion of these cells was completely abolished after pretreat-
ment with pertussis toxin suggesting that the chemotactic
signal was dependent on a Gai-coupled receptor (Fig. 2 B).
As a second, independent assay that determines respon-
siveness to SDF-1a we carried out actin polymerization
experiments with CD381 GC B cells versus CD382 B
cells. In this assay, changes in intracellular filamentous actin
(F-actin) were measured after exposure to SDF-1a over
time (29). There was a significant, transient increase in in-
tracellular F-actin in purified CD382 naive and memory B
cells within 15 s after addition of SDF-1a, whereas F-actin
in purified CD381 GC B cells showed little change com-
pared to sham-treated cells (Fig. 3). The observed rapid in-
crease in filamentous actin is characteristic for chemokine
induced actin polymerization and differs from stimulation
with phorbol esters and calcium ionophores (29, 42, 43).
The presented experiments suggest that B lymphocytes
participating in the GC reaction are unresponsive to
chemotactic stimulation by SDF-1a.
Differentiation State and Chemotaxis. The finding that the
differentiation state of a B lymphocyte correlates with its
responsiveness to chemokine prompted us to test if in vitro
differentiation of isolated cells would restore migratory
responses in the same cells. To this end we purified GC
B cells and differentiated them into memory type B
lymphocytes by culture on NIH3T3 cells expressing
CD40L over 7 d in the presence of IL-2 and IL-10 (30).
After 7 d, the majority of cultured cells had acquired the
CD382CD20intermediateCD441IgD2 phenotype that is char-
acteristic for memory B lymphocytes in vivo (Fig. 4 A).
L-selectin was induced and expression of intercellular ad-
hesion molecule 1, lymphocyte function-associated antigen
3, and B7.1 was increased on cultured GC B cells when
compared to GC B cells before culture (Fig. 4 B). These
surface antigens are known to participate in lymphocyte
homing and lymphocyte–lymphocyte interaction (44, 45).
In parallel, specific migration to SDF-1a of these cells in-
creased on average 27-fold during in vitro differentiation
(average of three independent experiments; Fig. 4 C). The
percentage of responsive cells among in vitro generated
memory B cells was consistently lower than in experiments
using isolated CD382 naive and memory B lymphocytes
(Fig. 2 A). This may suggest that additional signals other
than CD40L, IL-2, and IL-10 are necessary to fully recon-
stitute migratory properties in memory B lymphocytes.
BCR Cross-linking and Chemotaxis. Since recent find-
ings in the mouse suggest a key role for BCR engagement
in the localization of B cells within the white pulp in the
spleen (10, 11), we wished to determine what influence
signaling through the BCR would have on the responsive-
ness of naive and memory B cells. Therefore, we cross-
linked the BCR by incubating purified CD382 naive and
memory cells for 2 h with anti-kappa and -lambda light
chain mAbs in the presence of NIH3T3 cells that express
FcgRII (CD32). Compared to incubation with control
Figure 2. SDF-1a efficiently
attracts purified CD382 naive
and memory B lymphocytes by a
pertussis toxin–sensitive mecha-
nism. (A) B lymphocyte subsets
were isolated by negative selec-
tion with an mAb specific for
CD38 (to obtain naive and
memory B cells) or CD44 (to
obtain GC B cells) and tested in
the chemotaxis assay to an opti-
mal concentration of SDF-1a of
1.5 mg/ml. Results are shown as
specific migration, i.e., migration
above background migration to medium alone, and represent mean and standard deviation of three independent experiments. (B) Isolated CD382 naive
and memory B lymphocytes were transmigrated to an optimal concentration of SDF-1a after pretreatment with or without pertussis toxin (PT) over 2 h
at 378C. Control shows migration of sham treated cells to buffer alone. Columns and error bars show the mean and standard deviation of three indepen-
dent experiments.
Figure 3. Naive and memory, but not GC B lymphocytes respond to
SDF-1a by reorganization of the actin skeleton. Intracellular F-actin was
measured using FITC-labeled phalloidin in purified CD382 naive and
memory B cells (boxes) and CD381 GC B cells (circles) after addition of
SDF-1a at time 0 at a concentration of 1.5 mg/ml or in untreated CD382
naive and memory B cells (diamonds). Results are shown as percent of in-
tracellular F-actin relative to the value before addition of chemokine, and
are the mean and standard deviation of three independent experiments.758 B Lymphocyte Chemotaxis Regulated by Differentiation and BCR Engagement
IgG, this treatment reduced SDF-1a–mediated chemotaxis
consistently by 50% (Fig. 5 A). Treatment for longer than 2 h
did not result in additional reduction in migration indicat-
ing that BCR cross-linking regulates responsiveness to
Figure 4. In vitro differentiation of GC B lymphocytes into memory B
cells restores responsiveness to SDF-1a. (A) Two-color flow cytometry of
isolated GC B lymphocytes (left) and in vitro generated memory B cells
(right). GC B lymphocytes were cultured on CD40L expressing NIH3T3
cells in the presence of IL-2 and IL-10 for 7 d. Percentages of cells in the
respective quadrants are indicated. (B) Flow cytometric analysis of GC and in
vitro–generated memory B lymphocytes for homing receptors, adhesion,
and costimulatory molecules. Histograms show the number of cells (y-axis)
at each fluorescence intensity (log scale, x-axis). Specific mAb staining and
nonbinding control IgG1 staining are shown as open and filled curves, re-
spectively. (C) Migratory response of GC and in vitro–generated memory
B lymphocytes. Results are shown as specific migration to 1.5 mg/ml of
SDF-1a after subtraction of nonspecific migration to medium alone. The
phenotype (Fig. 4, A and B) and migratory response (Fig. 4 C) are from a
single experiment representative of three independent experiments.
Figure 5. B cell receptor engagement reduces the migratory response in
CD382 naive and memory B lymphocytes. (A) CD382 naive and memory B
cells were added to the chemotaxis assay after a 2-h incubation on FcgRII
(CD32) expressing NIH3T3 cells in the presence of the indicated mAbs and
migrated to an optimal concentration of SDF-1a of 1.5 mg/ml. mAbs to
lambda and kappa light chain and the control IgG1 were used at 2 mg/ml,
and the mAb to CD40 at 10 mg/ml. Results are expressed relative to the mi-
gration after incubation with control IgG1 and represent mean and standard
deviation of three independent experiments. (B) CD382 naive and memory
B cells were incubated on CD32-NIH3T3 cells in the presence of 2 mg/ml
mAb to lambda light chain and transmigrated to an optimal concentration of
SDF-1a of 1.5 mg/ml. Input (left) and transmigrated cells (right) were
stained for expression of kappa light chain.
SDF-1a within hours. Adding an mAb specific for CD40
to the combination of anti-kappa and -lambda light chain
mAbs under the same conditions led to an additional re-
duction in SDF-1a–induced migration (Fig. 5 A). In con-
trast, the anti-CD40 mAb alone had no effect on B cell
chemotaxis to SDF-1a (Fig. 5 A). To demonstrate the
specificity of the inhibitory effect of BCR cross-linking on
SDF-1a–induced migration, we incubated CD382 naive
and memory B cells for 2 h in the presence of NIH3T3
cells expressing FcgRII with a lambda light chain–specific
mAb alone. After chemotaxis to an optimal concentration
of SDF-1a, input and transmigrated cells were stained for
kappa light chain expression (Fig. 5 B). BCR cross-linking
with an mAb specific for lambda light chain consistently led
to a selective reduction in the percentage of lambda-expressing
B lymphocytes in the transmigrated population compared
to the input population, as shown by the increase in the
percentage of transmigrated B cells that expressed kappa
chain.
Differential Downregulation of CXCR4 by SDF-1a.
Chemokine directed migration is mediated through G pro-759 Bleul et al.
tein–coupled receptors. To investigate if the unresponsive-
ness of GC B lymphocytes was due to a lack of expression
of CXCR4, the receptor for SDF-1a, we stained tonsillar
B lymphocytes containing responsive and unresponsive
subsets with the CXCR4-specific mAb 12G5. We found
that both subsets express high levels of the receptor (Fig. 6 A).
Exposure to SDF-1a at 378C downregulated surface ex-
pression of CXCR4. Interestingly, receptors on CD382
naive and memory B cells were more rapidly downregu-
lated than on CD381 GC B cells in multiple experiments,
with a 73 and 54% decrease, respectively, after 30 min (Fig.
6 B). The same treatment with SDF-1a carried out at 48C
did not result in diminished binding of mAb 12G5 (not
shown). This finding indicates that the reduced binding of
CXCR4-specific mAb after treatment at 378C is due to
true downregulation of the receptor and not competition
of the antibody and the ligand for the same epitope.
Expression of SDF-1 in the Human Tonsil. To locate sites
of SDF-1 production within the human tonsil, we carried
out in situ hybridization studies on frozen sections of hu-
man tonsil. Using a RNA probe specific for both SDF-1a
and SDF-1b we detected message for SDF-1 in cells
present in the connective tissue that forms the stationary
scaffold of the tonsil and in nonlymphoid cells that sur-
round GCs (Fig. 7). Expression of SDF-1 was found to be
excluded from GCs and not to be associated with vascular
or epithelial components in the tonsillar tissue. The staining
found in the tonsil therefore suggests expression of SDF-1
in a specialized reticulum cell that lines the GC.
Discussion
SDF-1a induces migration in naive and memory B cells,
whereas GC B cells are unresponsive in assays measuring
chemotaxis and actin polymerization. B lymphocytes within
the GC maintain high levels of the SDF-1 receptor CXCR4.
Despite the expression of the appropriate chemokine re-
ceptor on these cells, there is no ligand-induced chemo-
taxis. Our studies further indicate that in comparison to na-
ive and memory B cells, on GC B cells CXCR4 is more
slowly removed from the surface after addition of SDF-1a.
Internalization of chemokine receptors within minutes af-
ter addition of agonist, as shown here for CXCR4 on naive
and memory B lymphocytes after addition of SDF-1a, has
been described for the fMLP and C5a receptors and is
thought to be an important mechanism to allow the con-
tinuous sampling of ambient chemoattractant concentration
that is necessary to follow a chemotactic gradient (46–48).
Figure 6. CXCR4 is more rapidly downregulated on responsive B
lymphocytes than on GC B cells. Phenotyping of human tonsillar B lym-
phocytes after treatment without (A) or with (B) 2 mg/ml SDF-1a for 30
min at 378C. The CD381 population corresponds to GC B cells, and the
CD382 population to naive and memory B cells. A reference dashed line
at 102 fluorescence units is shown for comparison between the panels.
Figure 7. Detection of SDF-1 mRNA in human tonsil by in situ hy-
bridization. Parallel frozen sections of human tonsil were either stained with
hematoxylin and eosin (A) or hybridized with digoxigenin-labeled anti-
sense (B) and sense (C) RNA probes specific for both SDF-1a and SDF-1b.
mRNA expression was visualized using alkaline phosphatase–conjugated
antidigoxigenin antibody and nitroblue tetrazolium salt/5-bromo-4-
chloro-3-indolyl phosphate. Sections are shown using 310 magnification.760 B Lymphocyte Chemotaxis Regulated by Differentiation and BCR Engagement
It seems that in GC B cells, CXCR4 is less coupled to
downstream regulators that induce internalization of recep-
tors than in migratory cells; there may be overlap between
these downstream regulators and those that signal chemo-
taxis.
The function of CXCR4 on GC B cells remains enig-
matic. SDF-1 has previously been described to promote
growth of pre–B cells and has therefore been termed PBSF
for pre–B cell growth-stimulating factor (19). We have car-
ried out preliminary experiments measuring apoptosis in
isolated GC B lymphocytes in the presence or absence of
SDF-1a and have failed to demonstrate a significant effect
on inhibition of apoptosis in these cells. In addition, our in
situ hybridization experiments indicate that expression of
SDF-1 is excluded from GCs. Thus, we have no indication
that SDF-1 serves as a growth factor or survival signal to
GC B cells that express its specific receptor CXCR4. It has
to be kept in mind that additional not yet identified factors
may use CXCR4 on B cells within GCs.
SDF-1a induces migration in naive and memory B cells,
but not in GC B cells. This observation suggests that B
lymphocytes undergoing somatic hypermutation within
GCs are unresponsive to cues that direct migration of naive
and memory B lymphocytes. In the mouse, Butcher’s
group has shown that purified PNAhi GC B cells compared
to B cells outside of the GC do not home to secondary
lymphoid organs when transferred into syngeneic recipients
(49). Although the lack of expression of the homing recep-
tor L-selectin is thought to be a factor, other mechanisms
are likely to be involved since homing to the spleen, which
is L-selectin independent (50), was also impaired (49). The
authors have proposed that the nonmigratory phase is a
transient phenomenon that is related to a specific differenti-
ation state within the confines of the GC microenviron-
ment and our observation that in vitro differentiation of
GC B cells towards a memory phenotype restores respon-
siveness to SDF-1 supports this notion.
Responsiveness of B lymphocytes to SDF-1a is regu-
lated by differentiation state and BCR signaling. In contrast
to the transition from unresponsive GC B cells to migra-
tory effector B lymphocytes that developed over days in
culture, the responsiveness to SDF-1a in CD382 naive and
memory cells decreased rapidly after BCR signaling. Only
hours after BCR cross-linking, naive and memory B cells
migrated significantly slower than control cells, and this ef-
fect was increased by concomitant signaling through CD40.
CD40 signaling by itself was ineffective. Thus, while re-
sponsiveness of naive and memory B lymphocytes to SDF-1a
is reduced after BCR cross-linking, these cells are thought
to migrate to the T cell areas of secondary lymphoid organs
after encounter of antigen (5, 51). This finding should not
be interpreted as contradictory to our results since SDF-1 is
unlikely to be the only chemotactic factor acting on B lym-
phocytes in lymphoid organs. Our finding may therefore
suggest that the reduced responsiveness to SDF-1 allows a
B cell after encounter of antigen to migrate along a gradi-
ent of a different chemotactic factor leading it into the T
cell area. In this context, our observation that SDF-1
mRNA is found in a specialized reticulum cell that lines
GCs in the tonsil is particularly striking. The expression of
mRNA for SDF-1 in nonlymphoid cells surrounding GCs
correlates with the position of small recirculating naive and
memory B lymphocytes in the tonsil (38). Our finding is
consistent with the previous isolation of SDF-1 protein or
mRNA from stromal cell lines, in this case derived from
the bone marrow (16, 19, 52). Our in situ hybridization re-
sults, therefore, further support the finding that responsive-
ness to SDF-1 correlates with the localization of B cell sub-
sets within the tonsil.
Much is known about the events that allow emigration
of lymphocytes from the bloodstream, through high endo-
thelial venules into secondary lymphoid organs (14, 15),
whereas little is known about the subsequent steps that di-
rect migration of B and T lymphocytes into their respective
microenvironments. Our study shows that subsets of B
lymphocytes within a secondary lymphoid organ respond
to SDF-1a and that this responsiveness correlates with a
specific localization within this lymphoid organ and is reg-
ulated by the differentiation state of the cell and by BCR
engagement. Migration of pro– and pre–B cells to SDF-1
has also recently been described in the mouse (53). Our
previous work demonstrated that naive and memory T
lymphocytes in the peripheral blood efficiently migrate to-
wards an SDF-1a gradient (16). Chemokines may be im-
portant to direct migration of lymphocytes into supportive
microenvironments and to maintain the specialized archi-
tecture of secondary lymphoid organs. Our work suggests
that SDF-1a may participate in this process, but further
work will be necessary to investigate the importance of
SDF-1 relative to other chemokines. The unresponsiveness
of GC B cells to SDF-1 may be due to alterations in down-
stream signaling pathways, and thus this may generalize to
other chemoattractant receptors. From work on the puta-
tive chemokine receptor BLR1, it becomes clear that dis-
tinct ligand–receptor pairs may be responsible for the posi-
tioning of B cells in the spleen and Peyer’s patches versus
mesenteric and peripheral lymph nodes, since GC architec-
ture is compromised in BLR1-deficient mice only in the
spleen and Peyer’s patches (13). The situation is compli-
cated by the fact that lymphocytes express multiple relevant
chemokine receptors that allow detection of multiple con-
centration gradients, and they may influence each other
within a given microenvironment. Further work will be
necessary to identify other B lymphocyte chemoattractants
to address these questions.
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